Lynx Analytics is an AI-native consulting firm founded in 2010 that helps pharmaceutical and life sciences organisations deploy data and AI solutions across their commercial and clinical operations. The company has spent more than 15 years working with major players including Genentech, AstraZeneca, Amgen, Roche, Gilead Sciences and Novo Nordisk to optimise decision-making across Medical Science Liaison, Marketing and Sales teams.
The firm operates from headquarters in Singapore with offices across the United States, Hong Kong and Hungary, plus additional operations in Canada, Germany and Indonesia. Its technical capabilities span generative AI, graph analytics, clinical trials optimisation, healthcare analytics and omnichannel engagement strategies. Lynx Analytics was founded by INSEAD students and professors, giving the company a strong research foundation that has evolved from pioneering work in graph analytics into a broader AI solutions practice.
The company offers LynxScribe, a generative AI platform, alongside bespoke consulting services designed to help pharmaceutical teams achieve launch excellence, optimise HCP engagement, allocate omnichannel investment more effectively and improve clinical trial design and execution.
